Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLIN: Colchicine in Acute Myocardial Infarction
NCT02363725Phase 2Completed
- Sponsor
- CHU Montpellier
- Start
- Dec 2014
- Primary completion
- May 2016
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of colchicine in acute myocardial infarction (AMI) (2 arms), sponsored by CHU Montpellier. Primary endpoint: Area Under the Curve of C-Reactive Protein at 5 days. Started Dec 2014; status: completed.
02
Drugs
colchicine
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT02363725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02363725.